<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a low-risk <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> patient who did not respond to erythropoietin alone, but who did show a major erythroid response to combination therapy consisting of erythropoietin and moxifloxacin </plain></SENT>
<SENT sid="1" pm="."><plain>This observation was exclusively empirical </plain></SENT>
<SENT sid="2" pm="."><plain>The immunomodulatory effects of moxifloxacin may explain the synergy with erythropoietin </plain></SENT>
</text></document>